Based on SEC filing data. A pharmaceutical corporation in Berkeley, CA raised $1.5M through a convertible note at the seed stage. The company is in early development with early-stage funding structure.
Get notified the moment Adheron Therapeutics, Inc. files a new round, hires execs, or shows traction signals.
Create free accountAbout this data
FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.